Cited by 20Cancer survivorship and carePain Management and Opioid UsePalliative and Oncologic Care

Antidepressant medication in patients with advanced cancer--an observational study

Lloyd-Williams, M., Payne, S., Reeve, J., Kolamunnage Dona, R.·2013·QJM

Abstract

OBJECTIVE: Literature reviews suggest limited evidence of efficacy of antidepressant medication in patients with advanced cancer. This study was carried out to observe the longitudinal effect of antidepressant medication in a cohort of advanced cancer patients. METHOD: Patients were recruited from hospice day care settings and followed up longitudinally by series of measures for depression for 6 months or until death. RESULTS: Six hundred and twenty nine patients recruited. One hundred and fifty six patients in total (25%) were receiving antidepressant medication for a median of 9.5 weeks (range 0-36 weeks) and a mean of 12.2 weeks. There was no significant difference in scores on depression measures over time for patients receiving antidepressant medication. CONCLUSION: Antidepressant medication for advanced cancer patients appeared to have little impact on depression scores. We postulate the holistic approaches within hospice day care may in themselves be interventions for depression thereby masking effect of pharmacological treatment. Further research should explore multi-intervention models for management of depression in advanced cancer.

Integrity signals

Registry

Crossref · 10.1093/qjmed/hct133

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Psychotherapy is the treatment of choice for depression ahead of pharmacological treatment in these patients due to poor tolerability and drug interactions of antidepressants, similar results between medication and placebo in cancer, and patient preference.

    “es el tratamiento de elección en depresión por delante del tratamiento farmacológico, por la mala tolerabilidad e interacciones farmacológicas de los antidepresivos en estos pacientes (27 ,28) , porque se han encontrado resultados similares entre la medicación y el placebo en personas con cáncer (29) , y porque los pacientes, tanto oncológicos como no oncológicos, suelen preferirla a la medicación”

Cites

Flagged first, then by citations

1 of the 28 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Lloyd-Williams, M., Payne, S., Reeve, J., & Kolamunnage Dona, R.
Affiliations
University of Liverpool (GB)
Venue
QJM
Published
2013-06-03
Volume
106
Issue
11
Pages
995-1001
ISSN
  • 0033-5622 (ISSN-L)
  • 1460-2725
  • 1460-2393
OpenAlex
W2042474539
Cited by
20
References
28
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 3
FWCI
1.25
Type
journal article
Language
en
Open access
closed
Locations
  • QJM (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute for Health and Care Research (NIHR/CS/009/013)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
Keywords
antidepressants, advanced cancer, depression, palliative care, holistic intervention, depression treatment
MeSH terms
Adult, Aged, Aged, 80 and over, Antidepressive Agents, Depression, England, Female, Humans, Longitudinal Studies, Male, Middle Aged, Neoplasms, Psychotherapy, Social Support, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review